EUCTR2015-003755-21-IT进行中（未招募）1 期
An Open-Label Extension Study of Volanesorsen Administered Subcutaneously to Patients with Familial Chylomicronemia Syndrome (FCS) - NA
ISIS PHARMACEUTICALS, INC.0 个研究点目标入组 68 人开始时间: 2020年2月11日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Satisfactory completion of ISIS 304801-CS6 or ISIS 304801-CS16 (index studies) with an acceptable safety profile
- •2. History of chylomicronemia
- •3. A diagnosis of Familial Chylomicronemia Syndrome (Type 1 Hyperlipoproteinemia)
- •4. Fasting triglycerides = 750 mg/dL (8.4 mmol/L) at Screening for the index studies
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 1
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 70
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Have any new condition or worsening of existing condition which in the opinion of the Investigator would make the patient unsuitable for enrollment, or could interfere with the patient participating in or
- •completing the study;
- •2. Unwilling to comply with lifestyle requirements for the duration of the study.
研究者
相似试验
进行中（未招募）
1 期
An open-label clinical trial of volanesorsen in patients with Familial Chylomicronemia Syndrome (FCS)Familial Chylomicronemia Syndrome (FCS)MedDRA version: 18.1Level: LLTClassification code 10017339Term: Fredrickson Type I lipidaemiaSystem Organ Class: 100000004850MedDRA version: 18.1Level: LLTClassification code 10060593Term: Fredrickson Type I lipidemiaSystem Organ Class: 100000004850EUCTR2015-003755-21-NLIonis Pharmaceuticals, Inc.70
进行中（未招募）
1 期
An open-label clinical trial of volanesorsen in patients with Familial Chylomicronemia Syndrome (FCS)Familial Chylomicronemia Syndrome (FCS)MedDRA version: 19.0Level: LLTClassification code 10017339Term: Fredrickson Type I lipidaemiaSystem Organ Class: 100000004850MedDRA version: 19.0Level: LLTClassification code 10060593Term: Fredrickson Type I lipidemiaSystem Organ Class: 100000004850EUCTR2015-003755-21-FRIonis Pharmaceuticals, Inc.70
进行中（未招募）
1 期
An open-label clinical trial of volanesorsen in patients with Familial Chylomicronemia Syndrome (FCS)Familial Chylomicronemia Syndrome (FCS)MedDRA version: 18.1 Level: LLT Classification code 10017339 Term: Fredrickson Type I lipidaemia System Organ Class: 100000004850MedDRA version: 18.1 Level: LLT Classification code 10060593 Term: Fredrickson Type I lipidemia System Organ Class: 100000004850EUCTR2015-003755-21-ESIonis Pharmaceuticals, Inc.70
进行中（未招募）
1 期
A study of the drug Volanesorsen (ISIS 304801) in children and adolescent patients with Familial Chylomicronemia Syndrome (FCS)Familial ChylomicronemiaSyndromeMedDRA version: 20.0Level: PTClassification code 10020606Term: HyperchylomicronaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2020-002997-28-NLAkcea Therapeutics, Inc.16
尚未招募
3 期
Open-Label Extension of VoxelotorHematology, Sickle Cell, DisorderSickle Cell DiseaseLBCTR2020063513Global Blood Therapeutics Inc.21